BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 24148741)

  • 1. Pleiotropic vascular protective effects of statins in perioperative medicine.
    Fang SY; Roan JN; Luo CY; Tsai YC; Lam CF
    Acta Anaesthesiol Taiwan; 2013 Sep; 51(3):120-6. PubMed ID: 24148741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy.
    Danesh FR; Kanwar YS
    FASEB J; 2004 May; 18(7):805-15. PubMed ID: 15117885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translating the effects of statins: from redox regulation to suppression of vascular wall inflammation.
    Antonopoulos AS; Margaritis M; Shirodaria C; Antoniades C
    Thromb Haemost; 2012 Nov; 108(5):840-8. PubMed ID: 22872079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pleiotropic effects of HMG-CoA reductase inhibitors.
    Bocan TM
    Curr Opin Investig Drugs; 2002 Sep; 3(9):1312-7. PubMed ID: 12498006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pleiotropic effects of statins: evidence for benefits beyond LDL-cholesterol lowering.
    Marzilli M
    Am J Cardiovasc Drugs; 2010; 10 Suppl 1():3-9. PubMed ID: 21391728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of statins on the proteasomal activity in mammalian endothelial and vascular smooth muscle cells.
    Ludwig A; Friedel B; Metzkow S; Meiners S; Stangl V; Baumann G; Stangl K
    Biochem Pharmacol; 2005 Aug; 70(4):520-6. PubMed ID: 15996638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pleiotropic effects of statins and related pharmacological experimental approaches.
    Alegret M; Silvestre JS
    Methods Find Exp Clin Pharmacol; 2006 Nov; 28(9):627-56. PubMed ID: 17200729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pleiotropic effects of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors: candidate mechanisms for anti-lipid deposition in blood vessels.
    Kumai T; Matsumoto N; Koitabashi Y; Takeba Y; Oonuma S; Sekine S; Tadokoro M; Kobayashi S
    Curr Med Chem Cardiovasc Hematol Agents; 2005 Jul; 3(3):195-201. PubMed ID: 15974884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro study over statins effects on cellular growth curves and its reversibility with mevalonate].
    Millan Núñez-Cortés J; Alvarez Rodriguez Y; Alvarez Novés G; Recarte Garcia-Andrade C; Alvarez-Sala Walther L
    Clin Investig Arterioscler; 2014; 26(1):1-9. PubMed ID: 24126321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins and direct vascular actions.
    Mueck AO; Seeger H
    Panminerva Med; 2003 Mar; 45(1):1-6. PubMed ID: 12682615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pleiotrophic effect of statins (3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors)].
    Igel M; Sudhop T; von Bergmann K
    Arzneimittelforschung; 2003; 53(8):545-53. PubMed ID: 13677244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermolecular differences of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors contribute to distinct pharmacologic and pleiotropic actions.
    Mason RP; Walter MF; Day CA; Jacob RF
    Am J Cardiol; 2005 Sep; 96(5A):11F-23F. PubMed ID: 16126019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond lipid-lowering: effects of statins on endothelial nitric oxide.
    Laufs U
    Eur J Clin Pharmacol; 2003 Mar; 58(11):719-31. PubMed ID: 12634978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering.
    Pedersen TR
    Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [HMG-CoA reductase inhibitors: anti-atherosclerotic effects other than lipid-lowering].
    Fujita R; Matsushima T
    Nihon Rinsho; 1999 Dec; 57(12):2821-5. PubMed ID: 10638219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of pleiotropic effects of statins in dementia.
    Crisby M
    Acta Neurol Scand Suppl; 2006; 185():115-8. PubMed ID: 16866920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statins and endothelial dysfunction.
    Larose E; Ganz P
    Semin Vasc Med; 2004 Nov; 4(4):333-46. PubMed ID: 15861315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HMG CoA reductase inhibition modulates VEGF-induced endothelial cell hyperpermeability by preventing RhoA activation and myosin regulatory light chain phosphorylation.
    Zeng L; Xu H; Chew TL; Eng E; Sadeghi MM; Adler S; Kanwar YS; Danesh FR
    FASEB J; 2005 Nov; 19(13):1845-7. PubMed ID: 16160062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The nonlipid effects of statins on endothelial function.
    Beckman JA; Creager MA
    Trends Cardiovasc Med; 2006 Jul; 16(5):156-62. PubMed ID: 16781949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The acute (cerebro)vascular effects of statins.
    Prinz V; Endres M
    Anesth Analg; 2009 Aug; 109(2):572-84. PubMed ID: 19608834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.